发明名称 |
5HT<sub>2C </sub>receptor modulators |
摘要 |
The present invention relates to novel compounds of Formula (I):;
which act as 5HT2C receptor modulators. These compounds are useful in pharmaceutical compositions whose use includes the treatment of obesity. |
申请公布号 |
US8846906(B2) |
申请公布日期 |
2014.09.30 |
申请号 |
US201213616981 |
申请日期 |
2012.09.14 |
申请人 |
Arena Pharmaceuticals, Inc. |
发明人 |
Smith Jeffrey;Smith Brian |
分类号 |
C07D223/14;C07D223/16;C07D487/00;C07D491/00;C07D403/04;C07D409/04;C07D491/04 |
主分类号 |
C07D223/14 |
代理机构 |
|
代理人 |
|
主权项 |
1. The compound that is N-trifluoroacetyl-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine. |
地址 |
San Diego CA US |